Variant report
Variant | esv2755279 |
---|---|
Chromosome Location | chr8:6063493-6073244 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77346722 | chr8:6065423-6065424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73188689 | chr8:6065424-6065425 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs535533150 | chr8:6065433-6065434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182090946 | chr8:6065445-6065446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186454860 | chr8:6065449-6065450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564541031 | chr8:6065463-6065464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148368932 | chr8:6065465-6065466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142248729 | chr8:6065489-6065490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146350250 | chr8:6065505-6065506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537755849 | chr8:6065534-6065535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555837183 | chr8:6065538-6065539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6980531 | chr8:6065543-6065544 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs541528095 | chr8:6065550-6065551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561803028 | chr8:6065559-6065560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572250104 | chr8:6065569-6065570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527938384 | chr8:6065570-6065571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541278056 | chr8:6065613-6065614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11779303 | chr8:6065615-6065616 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs533038430 | chr8:6065629-6065630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73516051 | chr8:6065637-6065638 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs59146209 | chr8:6065655-6065656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144450488 | chr8:6065667-6065668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549186114 | chr8:6065672-6065673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565882681 | chr8:6065678-6065679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150637126 | chr8:6065696-6065697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551516489 | chr8:6065761-6065762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571506911 | chr8:6065777-6065778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374593690 | chr8:6065793-6065794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537316334 | chr8:6065794-6065795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557648147 | chr8:6065827-6065828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575933838 | chr8:6065837-6065838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112740824 | chr8:6065838-6065839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555500590 | chr8:6065847-6065848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145711600 | chr8:6065852-6065853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541137195 | chr8:6065858-6065859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116147326 | chr8:6065895-6065896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141397613 | chr8:6065902-6065903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190611533 | chr8:6065927-6065928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369216799 | chr8:6065928-6065929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs367752591 | chr8:6065934-6065935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543319161 | chr8:6065959-6065960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563627284 | chr8:6066008-6066009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17076234 | chr8:6066009-6066010 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs76087175 | chr8:6066031-6066032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199968314 | chr8:6066055-6066056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397689569 | chr8:6066068-6066069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559332144 | chr8:6066071-6066072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182900126 | chr8:6066084-6066085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs58601971 | chr8:6066096-6066097 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs145292830 | chr8:6066114-6066115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6065400-6065800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
2 | chr8:6065400-6066200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr8:6065400-6067000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr8:6069000-6070600 | Weak transcription | Right Atrium | heart |
5 | chr8:6069600-6072800 | Enhancers | Fetal Brain Male | brain |
6 | chr8:6070000-6071400 | Enhancers | Fetal Brain Female | brain |
7 | chr8:6070400-6070600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr8:6070400-6070600 | Bivalent Enhancer | Hela-S3 | cervix |
9 | chr8:6070600-6070800 | Enhancers | Right Atrium | heart |
10 | chr8:6070600-6071200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
11 | chr8:6071400-6071800 | Weak transcription | Fetal Brain Female | brain |
12 | chr8:6071800-6072200 | Enhancers | Fetal Brain Female | brain |